The COVAX Facility's multilateral efforts have secured almost 2 billion doses of COVID-19 vaccine candidates for low-income and developing countries, several global health organizations said on Friday.
The organizations that co-lead COVAX — Gavi, the Vaccine Alliance, World Health Organization and Coalition for Epidemic Preparedness Innovations, or CEPI — said their agreements with several drugmakers mean that all of COVAX’s 190 participating and eligible member nations will have access to doses that protect vulnerable groups in the first half of 2021.
